These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 26125915)
1. Expression and clinical significance of PIWIL2 in hilar cholangiocarcinoma tissues and cell lines. Chen YJ; Xiong XF; Wen SQ; Tian L; Cheng WL; Qi YQ Genet Mol Res; 2015 Jun; 14(2):7053-61. PubMed ID: 26125915 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of Prdx1 in hilar cholangiocarcinoma: a predictor for recurrence and prognosis. Zhou J; Shen W; He X; Qian J; Liu S; Yu G Int J Clin Exp Pathol; 2015; 8(9):9863-74. PubMed ID: 26617696 [TBL] [Abstract][Full Text] [Related]
3. Metastasis-associated in colon cancer 1 is an independent prognostic biomarker for survival in Klatskin tumor patients. Lederer A; Herrmann P; Seehofer D; Dietel M; Pratschke J; Schlag P; Stein U Hepatology; 2015 Sep; 62(3):841-50. PubMed ID: 25953673 [TBL] [Abstract][Full Text] [Related]
4. Radical operation for hilar cholangiocarcinoma in comparable Eastern and Western centers: Outcome analysis and prognostic factors. Kimura N; Young AL; Toyoki Y; Wyatt JI; Toogood GJ; Hidalgo E; Prasad KR; Kudo D; Ishido K; Hakamada K; Lodge JPA Surgery; 2017 Sep; 162(3):500-514. PubMed ID: 28551378 [TBL] [Abstract][Full Text] [Related]
5. Elevated AQP1 Expression Is Associated With Unfavorable Oncologic Outcome in Patients With Hilar Cholangiocarcinoma. Li C; Li X; Wu L; Jiang Z Technol Cancer Res Treat; 2017 Aug; 16(4):421-427. PubMed ID: 27143047 [TBL] [Abstract][Full Text] [Related]
6. Prognostic factors and long-term outcomes of hilar cholangiocarcinoma: A single-institution experience in China. Hu HJ; Mao H; Shrestha A; Tan YQ; Ma WJ; Yang Q; Wang JK; Cheng NS; Li FY World J Gastroenterol; 2016 Feb; 22(8):2601-10. PubMed ID: 26937148 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of lymphovascular invasion in Bismuth-Corlette type IV hilar cholangiocarcinoma. Li B; Xiong XZ; Zhou Y; Wu SJ; You Z; Lu J; Cheng NS World J Gastroenterol; 2017 Sep; 23(36):6685-6693. PubMed ID: 29085213 [TBL] [Abstract][Full Text] [Related]
8. [Biopathological characteristics of hilar cholangiocarcinoma and the clinical significance]. Yu WL; Zhang YJ; Dong H; Yu H; Xian ZH; Wu MC; Cong WM Zhonghua Wai Ke Za Zhi; 2009 Aug; 47(15):1162-6. PubMed ID: 20021908 [TBL] [Abstract][Full Text] [Related]
9. Interleukin-8 is a prognostic indicator in human hilar cholangiocarcinoma. Sun Q; Li F; Sun F; Niu J Int J Clin Exp Pathol; 2015; 8(7):8376-84. PubMed ID: 26339407 [TBL] [Abstract][Full Text] [Related]
10. Can preoperative and postoperative CA19-9 levels predict survival and early recurrence in patients with resectable hilar cholangiocarcinoma? Wang JK; Hu HJ; Shrestha A; Ma WJ; Yang Q; Liu F; Cheng NS; Li FY Oncotarget; 2017 Jul; 8(28):45335-45344. PubMed ID: 28484084 [TBL] [Abstract][Full Text] [Related]
11. Relationship between serum MMP-9 level and prognosis after radical resection for Hilar cholangiocarcinoma patients. Li O; Yi W; Yang P; Guo C; Peng C Acta Cir Bras; 2019 Apr; 34(4):e201900409. PubMed ID: 31038586 [TBL] [Abstract][Full Text] [Related]
12. Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases. Ebata T; Nagino M; Kamiya J; Uesaka K; Nagasaka T; Nimura Y Ann Surg; 2003 Nov; 238(5):720-7. PubMed ID: 14578735 [TBL] [Abstract][Full Text] [Related]
13. [New criteria of radical surgery and long-term outcomes of hilar cholangiocarcinoma management]. Kovalenko YA; Vishnevsky VA; Chzhao AV; Zharikov YO Khirurgiia (Mosk); 2018; (8):4-11. PubMed ID: 30113586 [TBL] [Abstract][Full Text] [Related]
14. SPARCL1 is a novel predictor of tumor recurrence and survival in hilar cholangiocarcinoma. Yu Y; Chen Y; Ma J; Yu X; Yu G; Li Z Tumour Biol; 2016 Mar; 37(3):4159-67. PubMed ID: 26490986 [TBL] [Abstract][Full Text] [Related]
15. ADAM-17 is a poor prognostic indicator for patients with hilar cholangiocarcinoma and is regulated by FoxM1. Jiao X; Yu W; Qian J; Chen Y; Wei P; Fang W; Yu G BMC Cancer; 2018 May; 18(1):570. PubMed ID: 29776401 [TBL] [Abstract][Full Text] [Related]
16. Metallothionein overexpression and its prognostic relevance in intrahepatic cholangiocarcinoma and extrahepatic hilar cholangiocarcinoma (Klatskin tumors). Schmitz KJ; Lang H; Kaiser G; Wohlschlaeger J; Sotiropoulos GC; Baba HA; Jasani B; Schmid KW Hum Pathol; 2009 Dec; 40(12):1706-14. PubMed ID: 19683330 [TBL] [Abstract][Full Text] [Related]
17. Assessment of clinical outcomes of advanced hilar cholangiocarcinoma. Chen KJ; Yang FC; Qin YS; Jin J; Zheng SS Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):155-162. PubMed ID: 29636302 [TBL] [Abstract][Full Text] [Related]
18. Predictive factors of early recurrence after R0 resection of hilar cholangiocarcinoma: A single institution experience in China. Hu HJ; Jin YW; Shrestha A; Ma WJ; Wang JK; Liu F; Zhu YY; Zhou RX; Regmi P; Cheng NS; Li FY Cancer Med; 2019 Apr; 8(4):1567-1575. PubMed ID: 30868740 [TBL] [Abstract][Full Text] [Related]
19. Optimal indications for additional resection of the invasive cancer-positive proximal bile duct margin in cases of advanced perihilar cholangiocarcinoma. Oguro S; Esaki M; Kishi Y; Nara S; Shimada K; Ojima H; Kosuge T Ann Surg Oncol; 2015; 22(6):1915-24. PubMed ID: 25404474 [TBL] [Abstract][Full Text] [Related]
20. Actual Long-Term Survival Outcome of 403 Consecutive Patients with Hilar Cholangiocarcinoma. Kang MJ; Jang JY; Chang J; Shin YC; Lee D; Kim HB; Kim SW World J Surg; 2016 Oct; 40(10):2451-9. PubMed ID: 27206402 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]